United States · FDA National Drug Code directory
Abilify Asimtufii
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59148-114_284a898a-06c2-4ef9-9cb9-5d3e6cf94f9c
- Product NDC
- 59148-114
- Form
- INJECTION, SUSPENSION, EXTENDED RELEASE
- Composition / generic term
- Aripiprazole
- Labeler
- Otsuka America Pharmaceutical, Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 20230427
- Source listing expiry
- 20261231
Source-listed ingredients
- ARIPIPRAZOLE — 960 mg/3.2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (59148-114-80) / 3.2 mL in 1 SYRINGE · 59148-114-80
- 1 SYRINGE in 1 CARTON (59148-114-92) / 3.2 mL in 1 SYRINGE · 59148-114-92
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →